Skip to content
proxibarbal

Structure via PubChem · Public domain (PubChem)

EntityQ906452· pop 11· linked from 590 articles

proxibarbal

Sign in to save

Proxibarbital (Ipronal) is a barbiturate derivative synthesized in 1956 in Poland by Bogusław Bobrański. It has anti-anxiety and sedative properties and is, in contrast to most barbiturates, almost without hypnotic action. It was used as a sedative and anti-anxiety drug. It was also used in the treatment of migraine headaches in a similar manner to butalbital. It was a prescription drug available in Poland from the 1950s to the 1990s under trade name Ipronal.

Chemical data

Formula
C10H14N2O4
Molecular weight
226.23 g/mol
IUPAC name
5-(2-hydroxypropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione

via PubChem

Drug data · ChEMBL

Withdrawn
Max clinical phase
Approved
Molecule type
Small molecule

via ChEMBL · EBI

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Proxibarbital (Ipronal) is a barbiturate derivative synthesized in 1956 in Poland by Bogusław Bobrański. It has anti-anxiety and sedative properties and is, in contrast to most barbiturates, almost without hypnotic action. It was used as a sedative and anti-anxiety drug. It was also used in the treatment of migraine headaches in a similar manner to butalbital. It was a prescription drug available in Poland from the 1950s to the 1990s under trade name Ipronal.

Valofane isomerizes to proxibarbal in vivo.

Excerpted from Wikipedia’s “proxibarbal” article, available under the CC BY-SA 4.0 licence.